Illinois Prescription Monitoring Program

Update - June 2025

Subscribe to follow us @ILPMP on YouTube

View as Webpage

The ILPMP is announcing an important upcoming change regarding the reporting of controlled substances and current drugs of interest. By Illinois law, retail pharmacies and dispensing practitioners are required to electronically transmit a daily dispensing report not later than the end of the business day on which a controlled substance II-V or drug of interest is dispensed to the patient.

Effective July 1, 2025, the ILPMP will begin transitioning to the American Society for Automation in Pharmacy (ASAP) Version 5.0 format with a transition deadline of December 16, 2025. Pharmacies and software vendors should work proactively to update their systems and ensure compatibility with the new reporting format by the mandatory deadline.

This change is part of our ongoing commitment to improve data accuracy, enhance reporting capabilities, and align with national standards for prescription drug monitoring programs (PDMPs).

Key Dates:

• July 1, 2025 - ASAP testing window opens
• December 16, 2025 - ASAP format becomes mandatory for all data submitters

Drugs of Interest List revised to include drug classes

As part of this update, the ILPMP is also transitioning to a more generalized approach by categorizing drugs by class. This change allows for the automatic inclusion of new drugs approved by the Food and Drug Administration (FDA) within those classes. Pharmacies and dispensing physicians will be responsible for maintaining an up-to-date list of drugs within the specified classes to ensure accurate reporting.

What This Means for You

• Current submissions in the ASAP 4.2A format will continue to be accepted during the transition period.

•  Please contact LogiCoy via e-mail at ilpmp@logicoy.com to setup a test submission of the new ASAP 5.0 format. No files should be submitted in new format until this is complete.

• ASAP Version 5.0 is located on ILPMP.org / About Us / Pharmacy Reporting / Illinois Data Submitter Guide 

The ILPMP has released new guidance to help medical residents navigate the account registration process. The guidance outlines step-by-step instructions on how to create an ILPMP account and what credentials are needed. This update is part of the state's continued efforts to promote safe prescribing practices and ensure that all prescribers, including those in training, are equipped with the tools to help aid in making the best clinical decisions for patient outcomes.

SAMHSA Advisory: Expanding Access to Methadone in Hospital Settings

Substance Abuse and Mental Health Services Administration (SAMHSA) has released comprehensive information for hospitals and associated healthcare facilities on best practices and recommendations for implementing and expanding treatment of opioid use disorder with methadone in these settings.

Click HERE to read the full advisory.

Centers for Disease Control and Prevention provide Nonopioid therapies include both pharmacologic therapies (medication) and nonpharmacologic therapies. These methods include, but are not limited to, nonopioid medications, cognitive behavioral therapy, physical therapy, acupuncture, meditation, exercise, or interventional therapies like injections.

Working together, we can make Every Day Take Back Day. Scan the QR code or click image below to view Year-Round Drop Off locations for prescription drugs.

Newly Released, FREE, Continuing Education Available for Pharmacists and Pharmacy Technicians on the Importance of PMP Data Integrity

Take advantage of this free ACPE accredited educational opportunity providing 1 hour of continuing education for pharmacists and pharmacy technicians. This program, developed in partnership with NASCSA and 12 prescription monitoring program (PMP) administrators, analyzes the importance and value of complete, accurate data reported by dispensers to PMPs and assesses the impact of intentional or non-intentional data entry errors and data omissions on patient safety. It also discusses the downstream impacts of pharmacy-reported PMP data on clinical decision-making processes and helps pharmacy staff identify and implement changes that can be made in their practice setting to improve PMP data integrity.

Visit https://ce.talemhealth.com/a/MWEORC

If you received credit for this CE prior to 10/22/24, you are still able to retake the CE and receive credit.  

June 12, 2025 - Drs. Chris Herndon (Southern Illinois University Edwardsville) and David Liebovitz (Northwestern University) discuss the Illinois Prescription Monitoring Program Peer Review Committee.

Navigating Pain Management, Safe Opioid Prescribing, and Opioid Use Disorder

A three-hour program designed to meet the educational needs for physicians, nurses, and pharmacists. The program is accredited in 6, 30-minute modules.

If you have questions about the information that appears in this update or suggestions for future content, please email dhs.pmp@illinois.gov. Visit www.ilpmp.org for more information.

The Illinois Prescription Monitoring Program (ILPMP) is an electronic database that collects, tracks, and stores reported dispensing data on Schedule II-V controlled substances, selected drugs of interest, and other health information. The Illinois Department of Human Services oversees the ILPMP, authorized by the Illinois Controlled Substances Act (720 ILCS 570/316). The ILPMP adheres to HIPAA and all access, disclosure, and confidentiality provisions of Illinois Law.